NCT01702428 · Interventional trial
Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age
Overall registry status Completed
Phase 3
Conditions Measles, Mumps, Rubella
Delaware Valley sites
- GSK Investigational Site · Sellersville, PA · Bucks County
First posted
Registry updated
Added to the directory